Our partners
We focus on selling quality products from reputable companies that comply with national and European legislation.
Labor Dr.Merk - CZ
Labor Dr. Merk & Kollegen has more than 40 years of experience in manufacturing products for diagnostic and research purposes.
The company was founded as a start-up after the original Labor Dr. Merk & Kollegen became part of Boehringer Ingelheim Therapeutics. As Boehringer Ingelheim Therapeutics dropped some products from its portfolio, Labor Dr. Merk & Kollegen decided to continue with its established name in the production of well-known erythrocyte products and tests with its experienced staff to allow customers a seamless transition to the supply of the original products.
Institut Virion\Serion GmbH
Společnost Virion\Serion, founded in 1978, is a focused company that has grown over the past 40 years into a well-known and respected manufacturer of IVDs for the diagnosis of viral, bacterial, fungal and parasitic diseases worldwide.
Based on its extensive expertise in the production of high-quality antigens, Virion\Serion is also considered an important supplier of raw materials to the diagnostics industry. The product portfolio includes a range of tests for the diagnosis of infectious diseases in serum, plasma and liquor, including automation.
Mole Bioscience- CZ
Jiangsu Mole Bioscience Co., Ltd. ("Mole Bioscience") was established in 2008, a high-tech enterprise committed to the R&D, production and sales of in-vitro diagnostic test kits using the resources of Zhejiang University.
Mole Bioscience, based on industrialization platform, owns technologies for multiplex fluorescence quantitative PCR, high-throughput sequencing and antigen/antibody detection, product line includes respiratory infectious diseases, oncology, microbial antibiotic resistance, sexually transmitted diseases, enterovirus infections, tropical diseases, etc. Mole has successively carried out more than 30 national, provincial and municipal projects in China, meanwhile, the products have been exported to more than 60 countries overseas and won good recognition from partners and end users.